These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Bilheimer DW; Grundy SM; Brown MS; Goldstein JL Trans Assoc Am Physicians; 1983; 96():1-9. PubMed ID: 6388097 [TBL] [Abstract][Full Text] [Related]
6. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia. Grundy SM; Vega GL; Bilheimer DW Ann Intern Med; 1985 Sep; 103(3):339-43. PubMed ID: 3849281 [TBL] [Abstract][Full Text] [Related]
7. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754 [TBL] [Abstract][Full Text] [Related]
9. Brown and Goldstein: the cholesterol chronicles. Nair P Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14829-32. PubMed ID: 23980185 [No Abstract] [Full Text] [Related]
10. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia. Illingworth DR Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462 [TBL] [Abstract][Full Text] [Related]
11. Combination drug therapy for familial combined hyperlipidemia. East C; Bilheimer DW; Grundy SM Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029 [TBL] [Abstract][Full Text] [Related]
12. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia. Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197 [TBL] [Abstract][Full Text] [Related]
13. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up. Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923 [TBL] [Abstract][Full Text] [Related]
14. Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin. Illingworth DR; Connor WE Ann Intern Med; 1984 Jun; 100(6):850-1. PubMed ID: 6562870 [No Abstract] [Full Text] [Related]
15. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. Grundy SM; Bilheimer DW Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816 [TBL] [Abstract][Full Text] [Related]
17. The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone. Kitano Y; Thompson GR Ther Apher; 1997 May; 1(2):187-90. PubMed ID: 10225769 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of ml-236B in primary hypercholesterolemia. 1980. Yammoto A; Sudo H; Endo A Atheroscler Suppl; 2004 Oct; 5(3):43-50. PubMed ID: 15531274 [No Abstract] [Full Text] [Related]
19. The prediction of the therapeutic response to cholesterol lowering drugs in an 11-year-old boy with homozygous familial hypercholesterolaemia. Bakker HD; Bruin T; Schaap MC; Lansberg PJ; Kastelein JJ J Inherit Metab Dis; 1991; 14(3):389-92. PubMed ID: 1663193 [No Abstract] [Full Text] [Related]
20. Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil. Tilly-Kiesi M; Tikkanen MJ J Intern Med; 1991 May; 229(5):427-34. PubMed ID: 2040869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]